rs2228467

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001296.5(ACKR2):​c.122T>C​(p.Val41Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0567 in 1,614,140 control chromosomes in the GnomAD database, including 3,020 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.047 ( 233 hom., cov: 32)
Exomes 𝑓: 0.058 ( 2787 hom. )

Consequence

ACKR2
NM_001296.5 missense

Scores

5
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.05

Publications

50 publications found
Variant links:
Genes affected
ACKR2 (HGNC:1565): (atypical chemokine receptor 2) This gene encodes a beta chemokine receptor, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptor-mediated signal transduction are critical for the recruitment of effector immune cells to the inflammation site. This gene is expressed in a range of tissues and hemopoietic cells. The expression of this receptor in lymphatic endothelial cells and overexpression in vascular tumors suggested its function in chemokine-driven recirculation of leukocytes and possible chemokine effects on the development and growth of vascular tumors. This receptor appears to bind the majority of beta-chemokine family members; however, its specific function remains unknown. This gene is mapped to chromosome 3p21.3, a region that includes a cluster of chemokine receptor genes. [provided by RefSeq, Jul 2008]
CYP8B1 (HGNC:2653): (cytochrome P450 family 8 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the conversion of 7 alpha-hydroxy-4-cholesten-3-one into 7-alpha,12-alpha-dihydroxy-4-cholesten-3-one. The balance between these two steroids determines the relative amounts of cholic acid and chenodeoxycholic acid both of which are secreted in the bile and affect the solubility of cholesterol. This gene is unique among the cytochrome P450 genes in that it is intronless. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001296.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027184486).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0663 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001296.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACKR2
NM_001296.5
MANE Select
c.122T>Cp.Val41Ala
missense
Exon 3 of 3NP_001287.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACKR2
ENST00000422265.6
TSL:1 MANE Select
c.122T>Cp.Val41Ala
missense
Exon 3 of 3ENSP00000416996.1O00590
ACKR2
ENST00000442925.5
TSL:1
c.122T>Cp.Val41Ala
missense
Exon 2 of 2ENSP00000396150.1O00590
CYP8B1
ENST00000437102.1
TSL:1
c.1348-8153A>G
intron
N/AENSP00000404499.1C9JFR9

Frequencies

GnomAD3 genomes
AF:
0.0466
AC:
7092
AN:
152154
Hom.:
233
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.0956
Gnomad AMR
AF:
0.0478
Gnomad ASJ
AF:
0.0669
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0133
Gnomad FIN
AF:
0.0730
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0680
Gnomad OTH
AF:
0.0521
GnomAD2 exomes
AF:
0.0508
AC:
12775
AN:
251474
AF XY:
0.0522
show subpopulations
Gnomad AFR exome
AF:
0.0113
Gnomad AMR exome
AF:
0.0349
Gnomad ASJ exome
AF:
0.0738
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0787
Gnomad NFE exome
AF:
0.0713
Gnomad OTH exome
AF:
0.0578
GnomAD4 exome
AF:
0.0577
AC:
84372
AN:
1461868
Hom.:
2787
Cov.:
30
AF XY:
0.0572
AC XY:
41596
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0104
AC:
347
AN:
33480
American (AMR)
AF:
0.0366
AC:
1638
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0750
AC:
1961
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0157
AC:
1354
AN:
86258
European-Finnish (FIN)
AF:
0.0781
AC:
4173
AN:
53416
Middle Eastern (MID)
AF:
0.0687
AC:
396
AN:
5768
European-Non Finnish (NFE)
AF:
0.0640
AC:
71180
AN:
1111994
Other (OTH)
AF:
0.0550
AC:
3321
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
5219
10438
15658
20877
26096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2466
4932
7398
9864
12330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0465
AC:
7087
AN:
152272
Hom.:
233
Cov.:
32
AF XY:
0.0456
AC XY:
3396
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0108
AC:
448
AN:
41570
American (AMR)
AF:
0.0478
AC:
731
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0669
AC:
232
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.0128
AC:
62
AN:
4826
European-Finnish (FIN)
AF:
0.0730
AC:
773
AN:
10594
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0680
AC:
4623
AN:
68014
Other (OTH)
AF:
0.0516
AC:
109
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
347
693
1040
1386
1733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0606
Hom.:
1499
Bravo
AF:
0.0433
Asia WGS
AF:
0.00953
AC:
33
AN:
3478
EpiCase
AF:
0.0649
EpiControl
AF:
0.0724

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T
Eigen
Benign
0.035
Eigen_PC
Benign
0.048
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
2.0
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.087
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.040
D
Varity_R
0.17
gMVP
0.21
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2228467;
hg19: chr3-42906116;
COSMIC: COSV56177366;
COSMIC: COSV56177366;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.